Conditions & Recovery · NCI Cancer Currents Blog · June 16, 2026

Reflections on Progress and Partnership at ASCO 2026

Following ASCO 2026, NCI Director Dr. Anthony Letai reflects on the pace of progress in cancer research, efforts to accelerate clinical trials, and NCI’s role in supporting the cancer research and care community. He highlights how decades of investment in science are driving progress for patients and creating new opportunities to improve outcomes.

Originally published by NCI Cancer Currents Blog. We curate and add context; they did the reporting.

Read the full story at NCI Cancer Currents Blog ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor